DK2035432T3 - 2-(substitueret amino)-benzothiazolsulfonamid-HIV-proteaseinhibitorer - Google Patents

2-(substitueret amino)-benzothiazolsulfonamid-HIV-proteaseinhibitorer

Info

Publication number
DK2035432T3
DK2035432T3 DK07765554.6T DK07765554T DK2035432T3 DK 2035432 T3 DK2035432 T3 DK 2035432T3 DK 07765554 T DK07765554 T DK 07765554T DK 2035432 T3 DK2035432 T3 DK 2035432T3
Authority
DK
Denmark
Prior art keywords
substituted amino
protease inhibitors
hiv protease
benzothiazole sulfonamide
sulfonamide hiv
Prior art date
Application number
DK07765554.6T
Other languages
Danish (da)
English (en)
Inventor
Kock Herman De
Tim Hugo Maria Jonckers
Paul Jozef Gabriel Maria Boonants
Stefaan Julien Last
Inge Dierynck
Judith Eva Baumeister
T Klooster Gerben Albert Eleutherius Van
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of DK2035432T3 publication Critical patent/DK2035432T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK07765554.6T 2006-06-23 2007-06-22 2-(substitueret amino)-benzothiazolsulfonamid-HIV-proteaseinhibitorer DK2035432T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06116003 2006-06-23
PCT/EP2007/056235 WO2007147884A1 (en) 2006-06-23 2007-06-22 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Publications (1)

Publication Number Publication Date
DK2035432T3 true DK2035432T3 (da) 2012-05-14

Family

ID=37596252

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07765554.6T DK2035432T3 (da) 2006-06-23 2007-06-22 2-(substitueret amino)-benzothiazolsulfonamid-HIV-proteaseinhibitorer

Country Status (31)

Country Link
US (1) US8202887B2 (US20060241273A1-20061026-C00026.png)
EP (1) EP2035432B1 (US20060241273A1-20061026-C00026.png)
JP (1) JP5232776B2 (US20060241273A1-20061026-C00026.png)
KR (1) KR101419320B1 (US20060241273A1-20061026-C00026.png)
CN (1) CN101479275B (US20060241273A1-20061026-C00026.png)
AP (1) AP2069A (US20060241273A1-20061026-C00026.png)
AR (1) AR061619A1 (US20060241273A1-20061026-C00026.png)
AT (1) ATE544769T1 (US20060241273A1-20061026-C00026.png)
AU (1) AU2007262943B2 (US20060241273A1-20061026-C00026.png)
BR (1) BRPI0713487B1 (US20060241273A1-20061026-C00026.png)
CA (1) CA2653233C (US20060241273A1-20061026-C00026.png)
CL (1) CL2007001826A1 (US20060241273A1-20061026-C00026.png)
CY (1) CY1112971T1 (US20060241273A1-20061026-C00026.png)
DK (1) DK2035432T3 (US20060241273A1-20061026-C00026.png)
EA (1) EA016387B1 (US20060241273A1-20061026-C00026.png)
ES (1) ES2381129T3 (US20060241273A1-20061026-C00026.png)
HK (1) HK1125633A1 (US20060241273A1-20061026-C00026.png)
IL (1) IL195381A (US20060241273A1-20061026-C00026.png)
JO (1) JO2841B1 (US20060241273A1-20061026-C00026.png)
MX (1) MX2009000160A (US20060241273A1-20061026-C00026.png)
MY (1) MY146805A (US20060241273A1-20061026-C00026.png)
NZ (1) NZ573286A (US20060241273A1-20061026-C00026.png)
PE (1) PE20080342A1 (US20060241273A1-20061026-C00026.png)
PL (1) PL2035432T3 (US20060241273A1-20061026-C00026.png)
PT (1) PT2035432E (US20060241273A1-20061026-C00026.png)
SI (1) SI2035432T1 (US20060241273A1-20061026-C00026.png)
TW (1) TWI415851B (US20060241273A1-20061026-C00026.png)
UA (1) UA96445C2 (US20060241273A1-20061026-C00026.png)
UY (1) UY30416A1 (US20060241273A1-20061026-C00026.png)
WO (1) WO2007147884A1 (US20060241273A1-20061026-C00026.png)
ZA (1) ZA200810350B (US20060241273A1-20061026-C00026.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3090B1 (ar) * 2009-12-11 2017-03-15 Janssen Sciences Ireland Uc 5- امينو-4- هيدروكسي-بنتويل اميدات
MX2012015293A (es) 2010-07-02 2013-05-30 Gilead Sciences Inc Derivados de acido 2-quinolinil-acetico como compuestos antivirales.
EP2588450B1 (en) 2010-07-02 2017-05-24 Gilead Sciences, Inc. Napht-2-ylacetic acid derivatives to treat aids
US9024038B2 (en) * 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
EP3181555B1 (en) * 2011-04-21 2018-11-28 Gilead Sciences, Inc. Benzothiazole compounds and their pharmaceutical use
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
WO2013103724A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
US9096586B2 (en) 2012-04-20 2015-08-04 Gilead Sciences, Inc. Therapeutic compounds
WO2021209563A1 (en) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1370543T1 (sl) * 2001-02-14 2007-04-30 Tibotec Pharm Ltd Sirokospektralni 2-(substituirani-amino)-benzotiazol sulfonamidni inhibitorji HIV proteaze
TWI286476B (en) * 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
KR20050025647A (ko) * 2002-08-02 2005-03-14 티보텍 파마슈티칼즈 리미티드 광범위 2-아미노-벤조티아졸 설폰아미드 hiv프로테아제 저해제
EP1670448B1 (en) * 2003-09-30 2007-11-21 Tibotec Pharmaceuticals Ltd. Hcv inhibiting sulfonamides

Also Published As

Publication number Publication date
PL2035432T3 (pl) 2012-07-31
AU2007262943B2 (en) 2012-04-12
CN101479275B (zh) 2012-03-07
JP5232776B2 (ja) 2013-07-10
TW200817416A (en) 2008-04-16
EA016387B1 (ru) 2012-04-30
UY30416A1 (es) 2008-01-31
JO2841B1 (en) 2014-09-15
US8202887B2 (en) 2012-06-19
CA2653233A1 (en) 2007-12-27
PE20080342A1 (es) 2008-04-25
EP2035432B1 (en) 2012-02-08
US20090209583A1 (en) 2009-08-20
AU2007262943A1 (en) 2007-12-27
BRPI0713487B1 (pt) 2022-07-26
TWI415851B (zh) 2013-11-21
JP2009541272A (ja) 2009-11-26
NZ573286A (en) 2011-09-30
ATE544769T1 (de) 2012-02-15
KR101419320B1 (ko) 2014-07-14
EA200970052A1 (ru) 2009-04-28
AP2008004679A0 (en) 2008-12-31
CN101479275A (zh) 2009-07-08
IL195381A (en) 2013-01-31
HK1125633A1 (US20060241273A1-20061026-C00026.png) 2009-08-14
AP2069A (en) 2009-12-08
MY146805A (en) 2012-09-28
EP2035432A1 (en) 2009-03-18
PT2035432E (pt) 2012-04-24
BRPI0713487A2 (US20060241273A1-20061026-C00026.png) 2012-11-13
CA2653233C (en) 2015-09-29
KR20090024257A (ko) 2009-03-06
ZA200810350B (en) 2010-05-26
MX2009000160A (es) 2009-01-23
BRPI0713487A8 (pt) 2018-01-02
UA96445C2 (ru) 2011-11-10
WO2007147884A1 (en) 2007-12-27
IL195381A0 (en) 2009-08-03
SI2035432T1 (sl) 2012-06-29
CL2007001826A1 (es) 2008-01-18
ES2381129T3 (es) 2012-05-23
CY1112971T1 (el) 2016-04-13
AR061619A1 (es) 2008-09-10

Similar Documents

Publication Publication Date Title
LTPA2017010I1 (lt) Proteazomos inhibitoriai
DK2035432T3 (da) 2-(substitueret amino)-benzothiazolsulfonamid-HIV-proteaseinhibitorer
ATE530554T1 (de) Serinprotease-hemmer
ATE478070T1 (de) Heterozyklische aspartyl-proteasehemmer
ATE482214T1 (de) Aspartylproteasehemmer
ATE538092T1 (de) Asparaginsäureproteaseinhibitoren
BRPI0807547A2 (pt) Inibidores de aspartil protease hetercíclicos
ATE439835T1 (de) Heterozyklische aspartyl-proteasehemmer
DK1817276T3 (da) Cathepsin cysteine protease inhibitors
DE602005019971D1 (de) Inhibitoren von cysteinprotease
BRPI0810851A2 (pt) Compostos de enxofre com inibidores da serina protease ns3 do vírus da hepatite c
DK1848718T3 (da) E1 aktiveringsenzymhæmmere
DK1989206T3 (da) E1-aktiveringsenzymhæmmere
DK2526962T3 (da) Therapeutic application of Kazal-type serine protease inhibitors
DE602006010546D1 (de) N-(pyridin-2-yl)sulfonamidderivate
DK2041138T3 (da) Pyrroltriazinkinase-inhibitorer
DK2147098T3 (da) Anvendelse af proteinhydrolysater til stabilisering af metalloprotease-detergent-formuleringer
BRPI0807904A2 (pt) Inibidores das serina proteases para o tratamento de infecções de hcv
DK2086939T3 (da) Pyridiacarboxamid som II-beta-HSDI-inhibitorer
ATE536343T1 (de) Azapeptid-derivate als hiv-protease-inhibitoren
DK2032535T3 (da) Spiro-cycliske nitriler som protease-inhibitorer
DK1693027T3 (da) Fakoemulsifikationsspids
ATE429417T1 (de) Hiv-protease-inhibitoren
DK2066662T3 (da) Serinhydrolaseinhibitorer
DK1865940T3 (da) Alfaketoamidforbindelser som cysteinproteasehæmmere